Sofinnova Partners SAS

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sofinnova Partners SAS
CRD #164104
SEC #802-76686
CIK #0001574139
AUM
Employees
Phone0033176234100
Address711 Bd Haussmann
Paris, France
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($)
1.00.80.60.40.20.02011201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
VC Sofinnova Biovelocita II 2025-03-28 5.4
VC Sofinnova Capital Xi Co-Invest I 2025-03-28 0.5
VC Sofinnova Capital Xi SCSP SICAV-RAIF [2025-03-28] 54.0 3.1
PE Sofinnova Crossover II 2025-03-28 620.1
VC Sofinnova Digital Medicine I 2023-03-22 72.0
VC Sofinnova Capital X 2022-03-30 166.8
VC Sofinnova Industrial Biotech II 2022-03-30 77.5
VC Sofinnova COIV EIF 2020-06-16 11.2
VC Sofinnova MD Start III 2020-06-16 93.8
VC Sofinnova Capital IX 2019-06-21 237.8
PE Sofinnova Crossover I 2019-06-21 293.1
VC Sofinnova IT 2019-06-21 53.5
VC Sofinnova Telethon SCA RAIF 2019-06-21 49.3
VC Sofinnova Industrial Biotech I 2018-04-13 92.3
VC Sofinnova Capital VIII 2016-06-28 362.6
VC Sofinnova Capital VII 2013-08-30 50.7
VC Sofinnova Green Seed Fund 2013-08-30 25.6
VC Sofinnova Capital III 2012-05-09 1.3
VC Sofinnova Capital IV 2012-05-09 20.0
VC Sofinnova Capital V 2012-05-09 4.9
VC Sofinnova Capital VI [2012-05-09] 42.6
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors # Filings # Firms 2011 - 2025
Quentin Leveque 7
Antoine Papiernik 21
Graziano Seghezzi 6
Henrijette Richter 4
Sofinnova Partners 2
Christophe Blanche 1
Sofinnova Capital Xi GP SARL 1
EDGAR Form CIK 2011 - 2025
3 [0001574139]
4 [0001574139]
SC 13G [0001574139]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sofinnova Partners SAS Quince Therapeutics Inc [2025-02-14]
Sofinnova Partners SAS Quince Therapeutics Inc [2024-02-12]
Sofinnova Partners SAS DBV Technologies Sa [2015-02-17]
Sofinnova Partners SAS Proqr Therapeutics NV [2015-02-17]
Sofinnova Partners SAS Flexion Therapeutics Inc [2015-02-11]
Sofinnova Partners SAS Clovis Oncology Inc [2013-11-27]
Form 3/4/5 Subject 2011 - 2025
Sofinnova Partners SAS
CinCor Pharma, Inc.
Sofinnova Capital IX
HOOKIPA Pharma Inc.
Sofinnova Capital VI FCPR
Flexion Therapeutics Inc
Omthera Pharmaceuticals, Inc.
BioAmber Inc.
Terms | Privacy | Guide
tony@aum13f.com